OpenAI has integrated Codex into the GPT-5.4 framework, streamlining coding capabilities.
13 results for: gpt
AI Models Show Risks for Biological Misuse Amid Evolving Safeguards
Recent benchmarks reveal AI models may enable biological weaponization by low-expertise users, raising urgent policy concerns.
llm-openai-via-codex 0.1a0 Integrates LLM API with Codex CLI for Developers
The release of llm-openai-via-codex 0.1a0 simplifies API calls for developers using Codex CLI.
ChatGPT Images 2.0 Excels in Text Generation Capabilities
OpenAI's ChatGPT Images 2.0 model showcases a surprising proficiency in text generation.
OpenAI Makes ChatGPT Free for Verified U.S. Healthcare Professionals
OpenAI has announced that verified U.S. physicians, nurse practitioners, and pharmacists can now access ChatGPT for Clinicians at no charge.
OpenAI Adds Codex-Powered Workspace Agents to ChatGPT
OpenAI introduced workspace agents in ChatGPT: Codex-powered cloud agents designed to automate complex workflows and scale team work across tools securely.
Evaluates LLMs on Vietnamese legal text with a dual-aspect framework
An arXiv paper introduces a quantitative-plus-error-analysis benchmark for Vietnamese legal text, comparing GPT-4o, Claude 3 Opus, Gemini 1.5 Pro and Grok-1.
OpenAI Releases ChatGPT Images 2.0
OpenAI published ChatGPT Images 2.0; Simon Willison ran a Where's‑Waldo‑style prompt to compare it with gpt-image-1 and rival models.
Cloudflare Integrates OpenAI GPT-5.4 and Codex into Agent Cloud
Cloudflare has added OpenAI’s GPT-5.4 and Codex to its Agent Cloud so enterprises can build, deploy, and scale agentic workflows with an emphasis on speed and security.
OpenAI Launches GPT-Rosalind to Accelerate Life‑Sciences Research
OpenAI introduced GPT‑Rosalind, a frontier reasoning model aimed at speeding drug discovery, genomics, protein reasoning, and scientific workflows.
OpenAI opens GPT‑5.4‑Cyber to security vendors with $10M Trusted Access grants
OpenAI is placing GPT‑5.
OpenAI Debuts GPT-Rosalind for Drug Discovery and Genomics
OpenAI launched GPT-Rosalind, its first life‑sciences model aimed at accelerating drug discovery and genomic analysis and cutting long development timelines.
OpenAI pushes to lock users and expand enterprise in internal memo
CRO Denise Dresser told staff to prioritize user retention and enterprise sales and to build a product 'moat' as users easily switch between top models.